Heidi Alexander: “I agree that there are issues associated with animal drug compounding that should be examined. This bill does not change…”

“I agree that there are issues associated with animal drug compounding that should be examined. This bill does not change the current animal drug regulatory structure, and it is my hope that FDA would exercise its current enforcement authorities, as well as work with State pharmacy boards, to ensure that the law is being followed with respect to animal drug compounding, including compounding from bulk chemicals and the copying of approved drugs. In addition, Congress should utilize its oversight authorities to ensure that the agency acts accordingly. I plan to work with my colleagues in the Senate and the House to ask the Government Accountability Office to look at compounding of animal drugs.”